257 related articles for article (PubMed ID: 34689221)
1. Clinical significance of novel DNA methylation biomarkers for renal clear cell carcinoma.
Kubiliūtė R; Žukauskaitė K; Žalimas A; Ulys A; Sabaliauskaitė R; Bakavičius A; Želvys A; Jankevičius F; Jarmalaitė S
J Cancer Res Clin Oncol; 2022 Feb; 148(2):361-375. PubMed ID: 34689221
[TBL] [Abstract][Full Text] [Related]
2. Urine Molecular Biomarkers for Detection and Follow-Up of Small Renal Masses.
Žalimas A; Kubiliūtė R; Žukauskaitė K; Sabaliauskaitė R; Trakymas M; Letautienė S; Kaubrienė EM; Ušinskienė J; Ulys A; Jarmalaitė S
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555747
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation of PCDH8 is a potential prognostic biomarker for patients with clear cell renal cell carcinoma.
Lin YL; Wang YL; Fu XL; Ma JG
Med Sci Monit; 2014 Nov; 20():2380-5. PubMed ID: 25416427
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-30a-5p
Outeiro-Pinho G; Barros-Silva D; Aznar E; Sousa AI; Vieira-Coimbra M; Oliveira J; Gonçalves CS; Costa BM; Junker K; Henrique R; Jerónimo C
J Exp Clin Cancer Res; 2020 Jun; 39(1):98. PubMed ID: 32487203
[TBL] [Abstract][Full Text] [Related]
5. Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers.
Joosten SC; Odeh SNO; Koch A; Buekers N; Aarts MJB; Baldewijns MMLL; Van Neste L; van Kuijk S; Schouten LJ; van den Brandt PA; Tjan-Heijnen VC; van Engeland M; Smits KM
Clin Epigenetics; 2021 May; 13(1):103. PubMed ID: 33947447
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma.
Shen C; Liu J; Wang J; Zhong X; Dong D; Yang X; Wang Y
Int Immunopharmacol; 2020 Apr; 81():106274. PubMed ID: 32044664
[TBL] [Abstract][Full Text] [Related]
7. Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel.
Pires-Luís AS; Costa-Pinheiro P; Ferreira MJ; Antunes L; Lobo F; Oliveira J; Henrique R; Jerónimo C
J Transl Med; 2017 Jun; 15(1):149. PubMed ID: 28662726
[TBL] [Abstract][Full Text] [Related]
8. A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
Shi S; Ye S; Wu X; Xu M; Zhuo R; Liao Q; Xi Y
Yonsei Med J; 2019 Nov; 60(11):1013-1020. PubMed ID: 31637882
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of Gremlin1 (GREM1) promoter CpG island hypermethylation in clear cell renal cell carcinoma.
van Vlodrop IJ; Baldewijns MM; Smits KM; Schouten LJ; van Neste L; van Criekinge W; van Poppel H; Lerut E; Schuebel KE; Ahuja N; Herman JG; de Bruïne AP; van Engeland M
Am J Pathol; 2010 Feb; 176(2):575-84. PubMed ID: 20042676
[TBL] [Abstract][Full Text] [Related]
10. m6A RNA methylation regulators correlate with malignant progression and have potential predictive values in clear cell renal cell carcinoma.
Zhang QJ; Luan JC; Song LB; Cong R; Ji CJ; Zhou X; Xia JD; Song NH
Exp Cell Res; 2020 Jul; 392(1):112015. PubMed ID: 32333907
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and prognostic value of potential dependency genes in clear cell renal cell carcinoma based on a large-scale CRISPR-Cas9 and RNAi screening database DepMap.
Shi B; Ding J; Qi J; Gu Z
Int J Med Sci; 2021; 18(9):2063-2075. PubMed ID: 33850477
[TBL] [Abstract][Full Text] [Related]
12. A Four-Gene Promoter Methylation Marker Panel Consisting of
van Vlodrop IJH; Joosten SC; De Meyer T; Smits KM; Van Neste L; Melotte V; Baldewijns MMLL; Schouten LJ; van den Brandt PA; Jeschke J; Yi JM; Schuebel KE; Ahuja N; Herman JG; Aarts MJ; Bosman FT; Van Criekinge W; van Engeland M
Clin Cancer Res; 2017 Apr; 23(8):2006-2018. PubMed ID: 27756787
[No Abstract] [Full Text] [Related]
13. DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma.
Evelönn EA; Landfors M; Haider Z; Köhn L; Ljungberg B; Roos G; Degerman S
BMC Cancer; 2019 Jan; 19(1):65. PubMed ID: 30642274
[TBL] [Abstract][Full Text] [Related]
14. Identification of transforming growth factor beta induced (TGFBI) as an immune-related prognostic factor in clear cell renal cell carcinoma (ccRCC).
Du GW; Yan X; Chen Z; Zhang RJ; Tuoheti K; Bai XJ; Wu HH; Liu TZ
Aging (Albany NY); 2020 May; 12(9):8484-8505. PubMed ID: 32406866
[TBL] [Abstract][Full Text] [Related]
15.
Klümper N; Ralser DJ; Zarbl R; Schlack K; Schrader AJ; Rehlinghaus M; Hoffmann MJ; Niegisch G; Uhlig A; Trojan L; Steinestel J; Steinestel K; Wirtz RM; Sikic D; Eckstein M; Kristiansen G; Toma M; Hölzel M; Ritter M; Strieth S; Ellinger J; Dietrich D
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34446578
[TBL] [Abstract][Full Text] [Related]
16.
Lin W; Chen X; Chen T; Liu J; Ye Y; Chen L; Qiu X; Chia-Hsien Cheng J; Zhang L; Wu J; Qiu S
DNA Cell Biol; 2020 Jun; 39(6):1000-1011. PubMed ID: 32282241
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of DNA Methylation-Driven Genes in Clear Cell Renal Cell Carcinoma: A Study Based on Methylation and Transcriptome Analyses.
Hu M; Xie J; Hou H; Liu M; Wang J
Dis Markers; 2020; 2020():8817652. PubMed ID: 32733620
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome.
Fisel P; Kruck S; Winter S; Bedke J; Hennenlotter J; Nies AT; Scharpf M; Fend F; Stenzl A; Schwab M; Schaeffeler E
Clin Cancer Res; 2013 Sep; 19(18):5170-81. PubMed ID: 23881922
[TBL] [Abstract][Full Text] [Related]
19. Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma.
Xu WH; Xu Y; Tian X; Anwaier A; Liu WR; Wang J; Zhu WK; Cao DL; Wang HK; Shi GH; Qu YY; Zhang HL; Ye DW
J Cell Mol Med; 2020 Aug; 24(16):9012-9027. PubMed ID: 32567187
[TBL] [Abstract][Full Text] [Related]
20. An eleven metabolic gene signature-based prognostic model for clear cell renal cell carcinoma.
Wu Y; Wei X; Feng H; Hu B; Liu B; Luan Y; Ruan Y; Liu X; Liu Z; Wang S; Liu J; Wang T
Aging (Albany NY); 2020 Nov; 12(22):23165-23186. PubMed ID: 33221754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
